We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Exit Notice

You are about to leave ClinicalTrials.gov and go to: Phase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancer URL: https://pubmed.ncbi.nlm.nih.gov/17033039/

Click on the link to continue or return to ClinicalTrials.gov Home